Product Information
ICOSAPENT ETHYL 1 GRAM CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4408 per EA under NDC 70710159207. Its NADAC has been published 119 times since Jun 26, 2024.
FDA first approved this application on Apr 20, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710159207
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ICOSAPENT ETHYLApproval Type
Generic (ANDA)
FDA Application
ANDA217656FDA Approved
4/20/2023
TE Code
AB
On Market Since
8/4/2023
Price Statistics
The NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has been published 119 times since Jun 26, 2024, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4408 per EA |
|---|---|
| All-time high | $0.9297 (Jul 10, 2024) |
| All-time low | $0.4408 (Sep 23, 2026) |
| 52-week high | $0.5153 |
| 52-week low | $0.4408 |
| Median price | $0.5823 |
| Average price | $0.5868 |
| Largest weekly change | +35.6% (Aug 21, 2024) |
| Weeks tracked | 119 |
| Tracking since | Jun 26, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
icosapent ethyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ICOSAPENT ETHYL 1 GRAM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ICOSAPENT ETHYL 1 GRAM CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4408 per EA (NDC 70710159207), effective Sep 30, 2026.
How has the price of ICOSAPENT ETHYL 1 GRAM CAPSULE changed over time?
Over the history we have for it, the NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has declined 52.6%. It has been tracked across 119 weekly CMS publications since Jun 26, 2024.
What are the highest and lowest recorded NADAC prices for ICOSAPENT ETHYL 1 GRAM CAPSULE?
Since Jun 26, 2024, the NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has ranged from a low of $0.4408 (Sep 23, 2026) to a high of $0.9297 (Jul 10, 2024), with a median of $0.5823 per EA.
Are there cheaper alternatives to ICOSAPENT ETHYL 1 GRAM CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ICOSAPENT ETHYL 1 GRAM CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ICOSAPENT ETHYL 1 GRAM CAPSULE?
ICOSAPENT ETHYL 1 GRAM CAPSULE (NDC 70710159207) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.